WEST PHARMACEUTICAL SERVICES (WST) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:WST • US9553061055

246.16 USD
+2.6 (+1.07%)
At close: Feb 11, 2026
248.25 USD
+2.09 (+0.85%)
After Hours: 2/11/2026, 7:12:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Overall WST gets a fundamental rating of 7 out of 10. We evaluated WST against 58 industry peers in the Life Sciences Tools & Services industry. WST gets an excellent profitability rating and is at the same time showing great financial health properties. WST has a correct valuation and a medium growth rate. This makes WST very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year WST was profitable.
  • WST had a positive operating cash flow in the past year.
  • Each year in the past 5 years WST has been profitable.
  • WST had a positive operating cash flow in each of the past 5 years.
WST Yearly Net Income VS EBIT VS OCF VS FCFWST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • WST's Return On Assets of 11.98% is amongst the best of the industry. WST outperforms 93.10% of its industry peers.
  • With an excellent Return On Equity value of 16.11%, WST belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
  • WST's Return On Invested Capital of 14.78% is amongst the best of the industry. WST outperforms 89.66% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for WST is above the industry average of 13.23%.
Industry RankSector Rank
ROA 11.98%
ROE 16.11%
ROIC 14.78%
ROA(3y)15.07%
ROA(5y)15.52%
ROE(3y)20.26%
ROE(5y)21.56%
ROIC(3y)17.99%
ROIC(5y)18.35%
WST Yearly ROA, ROE, ROICWST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • WST has a Profit Margin of 16.29%. This is amongst the best in the industry. WST outperforms 86.21% of its industry peers.
  • WST's Profit Margin has improved in the last couple of years.
  • The Operating Margin of WST (20.71%) is better than 87.93% of its industry peers.
  • In the last couple of years the Operating Margin of WST has grown nicely.
  • Looking at the Gross Margin, with a value of 35.58%, WST is doing worse than 60.34% of the companies in the same industry.
  • WST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.71%
PM (TTM) 16.29%
GM 35.58%
OM growth 3Y-8.66%
OM growth 5Y4.7%
PM growth 3Y-10.02%
PM growth 5Y5.33%
GM growth 3Y-6.03%
GM growth 5Y0.95%
WST Yearly Profit, Operating, Gross MarginsWST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), WST is creating some value.
  • WST has less shares outstanding than it did 1 year ago.
  • WST has less shares outstanding than it did 5 years ago.
  • WST has a worse debt/assets ratio than last year.
WST Yearly Shares OutstandingWST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
WST Yearly Total Debt VS Total AssetsWST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • WST has an Altman-Z score of 13.01. This indicates that WST is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 13.01, WST belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
  • The Debt to FCF ratio of WST is 0.55, which is an excellent value as it means it would take WST, only 0.55 years of fcf income to pay off all of its debts.
  • WST's Debt to FCF ratio of 0.55 is amongst the best of the industry. WST outperforms 91.38% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that WST is not too dependend on debt financing.
  • WST has a Debt to Equity ratio of 0.07. This is in the better half of the industry: WST outperforms 63.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.55
Altman-Z 13.01
ROIC/WACC1.35
WACC10.92%
WST Yearly LT Debt VS Equity VS FCFWST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 2.87 indicates that WST has no problem at all paying its short term obligations.
  • WST has a Current ratio (2.87) which is in line with its industry peers.
  • A Quick Ratio of 2.18 indicates that WST has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.18, WST perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.18
WST Yearly Current Assets VS Current LiabilitesWST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.59% over the past year.
  • WST shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.81% yearly.
  • The Revenue has been growing slightly by 4.92% in the past year.
  • The Revenue has been growing by 9.48% on average over the past years. This is quite good.
EPS 1Y (TTM)4.59%
EPS 3Y-7.79%
EPS 5Y15.81%
EPS Q2Q%5.95%
Revenue 1Y (TTM)4.92%
Revenue growth 3Y0.72%
Revenue growth 5Y9.48%
Sales Q2Q%7.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.12% on average over the next years. This is quite good.
  • Based on estimates for the next years, WST will show a small growth in Revenue. The Revenue will grow by 6.45% on average per year.
EPS Next Y6.29%
EPS Next 2Y7.84%
EPS Next 3Y9.51%
EPS Next 5Y10.12%
Revenue Next Year6.25%
Revenue Next 2Y6.26%
Revenue Next 3Y6.44%
Revenue Next 5Y6.45%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WST Yearly Revenue VS EstimatesWST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
WST Yearly EPS VS EstimatesWST Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 34.82, which means the current valuation is very expensive for WST.
  • WST's Price/Earnings ratio is in line with the industry average.
  • WST is valuated rather expensively when we compare the Price/Earnings ratio to 28.23, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 31.36, the valuation of WST can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of WST indicates a somewhat cheap valuation: WST is cheaper than 60.34% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. WST is around the same levels.
Industry RankSector Rank
PE 34.82
Fwd PE 31.36
WST Price Earnings VS Forward Price EarningsWST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, WST is valued a bit cheaper than 67.24% of the companies in the same industry.
  • WST's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. WST is cheaper than 62.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.71
EV/EBITDA 21.64
WST Per share dataWST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WST does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of WST may justify a higher PE ratio.
PEG (NY)5.53
PEG (5Y)2.2
EPS Next 2Y7.84%
EPS Next 3Y9.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • WST has a yearly dividend return of 0.32%, which is pretty low.
  • WST's Dividend Yield is rather good when compared to the industry average which is at 0.09. WST pays more dividend than 86.21% of the companies in the same industry.
  • With a Dividend Yield of 0.32, WST pays less dividend than the S&P500 average, which is at 1.79.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of WST has a limited annual growth rate of 5.90%.
  • WST has paid a dividend for at least 10 years, which is a reliable track record.
  • WST has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.9%
Div Incr Years32
Div Non Decr Years34
WST Yearly Dividends per shareWST Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • WST pays out 12.34% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of WST is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12.34%
EPS Next 2Y7.84%
EPS Next 3Y9.51%
WST Yearly Income VS Free CF VS DividendWST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
WST Dividend Payout.WST Dividend Payout, showing the Payout Ratio.WST Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

WEST PHARMACEUTICAL SERVICES

NYSE:WST (2/11/2026, 7:12:12 PM)

After market: 248.25 +2.09 (+0.85%)

246.16

+2.6 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-23
Earnings (Next)02-12
Inst Owners97.92%
Inst Owner Change-1.93%
Ins Owners0.33%
Ins Owner Change0%
Market Cap17.71B
Revenue(TTM)3.02B
Net Income(TTM)491.70M
Analysts80.91
Price Target353.41 (43.57%)
Short Float %2.68%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.81
Dividend Growth(5Y)5.9%
DP12.34%
Div Incr Years32
Div Non Decr Years34
Ex-Date01-28
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.04%
Min EPS beat(2)15.4%
Max EPS beat(2)20.68%
EPS beat(4)4
Avg EPS beat(4)14.32%
Min EPS beat(4)4.78%
Max EPS beat(4)20.68%
EPS beat(8)7
Avg EPS beat(8)11.13%
EPS beat(12)11
Avg EPS beat(12)13.12%
EPS beat(16)14
Avg EPS beat(16)10.97%
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)1.1%
Max Revenue beat(2)4.33%
Revenue beat(4)4
Avg Revenue beat(4)1.58%
Min Revenue beat(4)0.12%
Max Revenue beat(4)4.33%
Revenue beat(8)6
Avg Revenue beat(8)0.82%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)0.44%
PT rev (1m)-0.18%
PT rev (3m)0.33%
EPS NQ rev (1m)-0.08%
EPS NQ rev (3m)-0.19%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 34.82
Fwd PE 31.36
P/S 5.87
P/FCF 46.71
P/OCF 25.52
P/B 5.8
P/tB 6.04
EV/EBITDA 21.64
EPS(TTM)7.07
EY2.87%
EPS(NY)7.85
Fwd EY3.19%
FCF(TTM)5.27
FCFY2.14%
OCF(TTM)9.64
OCFY3.92%
SpS41.95
BVpS42.42
TBVpS40.76
PEG (NY)5.53
PEG (5Y)2.2
Graham Number82.14
Profitability
Industry RankSector Rank
ROA 11.98%
ROE 16.11%
ROCE 18.01%
ROIC 14.78%
ROICexc 18.05%
ROICexgc 18.84%
OM 20.71%
PM (TTM) 16.29%
GM 35.58%
FCFM 12.56%
ROA(3y)15.07%
ROA(5y)15.52%
ROE(3y)20.26%
ROE(5y)21.56%
ROIC(3y)17.99%
ROIC(5y)18.35%
ROICexc(3y)23.92%
ROICexc(5y)24.8%
ROICexgc(3y)25.26%
ROICexgc(5y)26.44%
ROCE(3y)21.92%
ROCE(5y)22.37%
ROICexgc growth 3Y-17.09%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-16.41%
ROICexc growth 5Y3.44%
OM growth 3Y-8.66%
OM growth 5Y4.7%
PM growth 3Y-10.02%
PM growth 5Y5.33%
GM growth 3Y-6.03%
GM growth 5Y0.95%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.55
Debt/EBITDA 0.26
Cap/Depr 190.61%
Cap/Sales 10.43%
Interest Coverage 250
Cash Conversion 87.8%
Profit Quality 77.1%
Current Ratio 2.87
Quick Ratio 2.18
Altman-Z 13.01
F-Score6
WACC10.92%
ROIC/WACC1.35
Cap/Depr(3y)247.41%
Cap/Depr(5y)221.86%
Cap/Sales(3y)11.72%
Cap/Sales(5y)10.45%
Profit Quality(3y)66.98%
Profit Quality(5y)67.4%
High Growth Momentum
Growth
EPS 1Y (TTM)4.59%
EPS 3Y-7.79%
EPS 5Y15.81%
EPS Q2Q%5.95%
EPS Next Y6.29%
EPS Next 2Y7.84%
EPS Next 3Y9.51%
EPS Next 5Y10.12%
Revenue 1Y (TTM)4.92%
Revenue growth 3Y0.72%
Revenue growth 5Y9.48%
Sales Q2Q%7.73%
Revenue Next Year6.25%
Revenue Next 2Y6.26%
Revenue Next 3Y6.44%
Revenue Next 5Y6.45%
EBIT growth 1Y6.71%
EBIT growth 3Y-8.01%
EBIT growth 5Y14.63%
EBIT Next Year37.43%
EBIT Next 3Y18.61%
EBIT Next 5Y15.08%
FCF growth 1Y-9.74%
FCF growth 3Y-5.79%
FCF growth 5Y2.8%
OCF growth 1Y-9.68%
OCF growth 3Y3.81%
OCF growth 5Y12.22%

WEST PHARMACEUTICAL SERVICES / WST FAQ

What is the fundamental rating for WST stock?

ChartMill assigns a fundamental rating of 7 / 10 to WST.


What is the valuation status for WST stock?

ChartMill assigns a valuation rating of 4 / 10 to WEST PHARMACEUTICAL SERVICES (WST). This can be considered as Fairly Valued.


Can you provide the profitability details for WEST PHARMACEUTICAL SERVICES?

WEST PHARMACEUTICAL SERVICES (WST) has a profitability rating of 8 / 10.


Can you provide the financial health for WST stock?

The financial health rating of WEST PHARMACEUTICAL SERVICES (WST) is 8 / 10.


How sustainable is the dividend of WEST PHARMACEUTICAL SERVICES (WST) stock?

The dividend rating of WEST PHARMACEUTICAL SERVICES (WST) is 6 / 10 and the dividend payout ratio is 12.34%.